4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01)

Patent

CA 2736362

Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are 4-amino-3-imidazoyl-pyrazolo[3,4-d]pyrimidine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated disease, and as controls in assays for the identification of competitive CCR1 antagonists.

La présente invention concerne des composés qui constituent de puissants antagonistes du récepteur CCR1, et qui présentent in vivo une activité anti-inflammatoire. Ces composés dérivés de 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines, conviennent particulièrement pour l'élaboration de compositions pharmaceutiques, pour le traitement de maladies médiées par CCR1, et comme témoins pour l'identification d'antagonistes compétitifs de CCR1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1787823

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.